Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)-Reference-Cited by-同舟云学术

Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)

Published:2017-05-31 Issue:4 Volume:10 Page:337-347
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Wasiak Sylwia,Gilham Dean,Tsujikawa Laura M.,Halliday Christopher,Calosing Cyrus,Jahagirdar Ravi,Johansson Jan,Sweeney Michael,Wong Norman C.,Kulikowski Ewelina^ORCID

Funder

Resverlogix Corp

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

http://link.springer.com/article/10.1007/s12265-017-9755-z/fulltext.html

Reference52 articles.

1. Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015). Complement system part I—molecular mechanisms of activation and regulation. Frontiers in Immunology, 6, 262. doi: 10.3389/fimmu.2015.00262 .

2. Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., et al. (2010). Molecular intercommunication between the complement and coagulation systems. Journal of Immunology, 185(9), 5628–5636. doi: 10.4049/jimmunol.0903678 .

3. Carter, A. M. (2012). Complement activation: an emerging player in the pathogenesis of cardiovascular disease. Scientifica (Cairo), 2012, 402783. doi: 10.6064/2012/402783 .